Characterization and Support for Neurodevelopmental Disorders Associated with Congenital Heart Defects

NARecruitingINTERVENTIONAL
Enrollment

1,206

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

August 8, 2025

Conditions
Congenital Heart DefectsNeurodevelopmental Disorder
Interventions
OTHER

Blood sampling

An EDTA blood sample will be taken from the children and their two parents. Sample volume will be 2 x 3mL.

DIAGNOSTIC_TEST

Assessment of neurodevelopment (CA)

The children will be seen by a neuropsychologist, who will then determine whether or not they have neurodevelopmental disorders.

DIAGNOSTIC_TEST

Assessment of neurodevelopment (Nantes)

The children will be seen by a multidisciplinary team (including a neuropsychologist), who will then determine whether or not they have neurodevelopmental disorders.

OTHER

Assessment of the parental stress

Parents' parental stress will be assessed using the Parental Stress Index (PSI) questionnaire.

Trial Locations (5)

29200

NOT_YET_RECRUITING

Chu Brest, Brest

35000

NOT_YET_RECRUITING

CHU Rennes, Rennes

37000

NOT_YET_RECRUITING

CHU Tours, Tours

44000

RECRUITING

CHU Nantes, Nantes

49000

NOT_YET_RECRUITING

CHU Angers, Angers

All Listed Sponsors
collaborator

University of Angers - Pays de la Loire psychology laboratory

UNKNOWN

lead

Nantes University Hospital

OTHER